Skip to main content
. 2021 Jul 7;65(6):501–509. doi: 10.1159/000517078

Fig. 1.

Fig. 1

An adenocarcinoma with concordant PD-L1 expression (both ≥50%) between paired EBUS cytology (a, b) and bronchial biopsy (c, d). Hematoxylin-eosin (a, c) and PD-L1 clone 22C3 (b, d). Scale bar, 20 μm. PD-L1, programmed death-ligand 1; EBUS, endobronchial ultrasound.